WaveMan
WaveMan · Company
HCTI · Healthcare Triangle, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

HCTI Healthcare Triangle (HCTI) Insider Trading, Ownership & Congress Trades

Software & IT · Services-computer integrated systems design · CIK 0001839285
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
4
13F, latest reported quarter

Healthcare Triangle insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for Healthcare Triangle, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing

no insider purchases or sales on record

0 transactions on record
See all insider buying · insider selling
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
4 funds bought in last quarter
below 97% of Software & IT
Revenue
+18.8% year over year
more than 69% of Software & IT
Margin
-68.2% net margin
below 81% of Software & IT
Buybacks
no share repurchases reported
Short interest
33.8% of the float short (float per yahoo 2026-10-27) · 1.0 days to cover · settled 2026-10-15
below 59% of Software & IT
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch HCTI

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-95.8%12M
-100%-62%-25%+12%2025-102025-122026-022026-042026-062026-082026-10
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns HCTI: institutional holders (13F)

13F holdings, latest reported quarter
BANK OF MONTREAL /CAN/
20,000 sh
$36.2K
GEODE CAPITAL MANAGEMENT, LLC
11,975 sh
$21.7K
UBS Group AG
8,859 sh
$16.0K
Tower Research Capital LLC (TRC)
1,314 sh
$2.4K
VANGUARD CAPITAL MANAGEMENT LLC
859 sh
$1.6K

Congress trades in HCTI

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

HCTI planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

HCTI mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Invesco BuyBack AchieversTM ETF
$1.9K position · as of 2026-07-31
0.0%
Fidelity Extended Market Index Fund
$28.1K position · as of 2026-05-31
0.0%
Fidelity Series Total Market Index Fund
$2.2K position · as of 2026-05-31
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$1.6K position · as of 2026-06-30
0.0%
Fidelity Nasdaq Composite Index Fund
$90 position · as of 2026-05-31
0.0%
Fidelity Total Market Index Fund
$361 position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 4 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
TEAMMETACRWVCRMCRWDNETDDOGAPPIOTPCTYDUOLMDB

HCTI financials

Revenue growth
+18.8%
XBRL, annual
Net margin
-68.2%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$25.7M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-66.3%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$21.2M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.17x
LongTermDebt as filed 2026-06-30 (includes the current portion); equity 2026-06-30
Cash flow to debt
-1.98x
TTM operating cash flow over LongTermDebt as filed 2026-06-30 (includes the current portion)
Return on equity
-57.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-38.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on capital employed
-42.7%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$108.6M
market value at close 2026-10-26 on 2026-08-12 shares, plus LongTermDebt as filed 2026-06-30 (includes the current portion), minus cash 2026-06-30
FCF yield
-20.7%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$13.9M$11.7M$33.2M$45.9M
Gross profit$1.2B$1.1B$1.1Bn/a
Operating income-$9.8M-$4.8M-$7.7M-$16.3M
Net income-$9.5M-$6.0M-$8.7M-$14.4M
EPS (diluted)-152.30-16,909.30-2.08-3.88
Operating cash flow-$16.5M-$1.1M-$2.2M-$5.4M
Cash$7.6M$20.0K$1.2M$1.3M
Long-term debt$1.0B$1.0B$888.0Kn/a
Buybacksn/an/an/a$141.0K
SEC XBRL, fiscal years, as known on 2026-10-28

HCTI Stock Sonar score 5/7 axes

Find similar shapesCompare

HCTI ranks highest on growth (69th percentile) and risk and compliance (49th), and lowest on institutional and government (3rd), among Software & IT peers.

ProfitHealthGrowthInstitutionsRisk
Profitability
19
Inputs
  • Return on equity-57.4% · 18 pct, sector of 286
  • Return on assets-38.6% · 23 pct, sector of 381
  • Return on invested capitaltax provision or pre-tax income not filed for the four quarters
  • Return on capital employed-42.7% · 17 pct, sector of 294
Financial health
34
Inputs
  • Debt to equity0.17x · 51 pct, sector of 288
  • Cash flow to debt-1.98x · 18 pct, sector of 241
Growth
69
Inputs
  • Revenue growth, YoY+18.8% · 69 pct, sector of 480
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
3
Inputs
  • Funds adding, latest quarter4 · 3 pct, sector of 415
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
49
Inputs
  • Short interest, % of float+33.8% · 2 pct, sector of 528
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+1.0% · 97 pct, sector of 316
2 not measured: Insider conviction, US patents
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies